IPO Trending
VILINBIOSME / NSEListed

Vilin Bio Med Limited

Incorporated in 2005, Vilin Bio Med Limited is engaged in the domestic manufacturing of pharmaceutical products, supplying in bulk to pharmaceutical manufacturers, marketers, and traders who distribute them to end customers. The company’s product range includes Oral Liquids (Syrups, Suspensions, Dry Powders – both βeta and Non-βeta-Lactam), Tablets and Capsules (βeta and Non-βeta-Lactam), External Preparations, and Dry Powders. Vilin Bio Med operates its R&D center and manufacturing facility in Roorkee, Uttarakhand, ensuring quality and innovation in production. The company reported revenue of ₹1,121.91 lakhs in FY2022 and ₹1,171.88 lakhs in FY2021.

₹30 - ₹302.82x sub
Listed Price30.00
Listing Gain+0.00%
Subscription2.82x total demandUpdated 11 Nov 2025, 07:55 AM
Nib1.48x
Fully Subscribed (Safe)Offered: 17,92,000 sh
Retail4.02x
Popular / Warm DemandOffered: 20,00,000 sh
CategoryOfferedAppliedTimes
Nib17,92,00026,44,0001.48x
Retail20,00,00080,40,0004.02x
Segment Subscription Demand
Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
Retail24.1264.02x